Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publication : acta oncologica

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Agent orange exposure and prostate cancer risk in the million veteran program.

Authors : Pagadala, Meghana S.^1,2,3; Lui, Asona J.⁴; Zhong, Allison Y.⁴

Source: Acta Oncologica. 2024 Special Issue, Vol. 63, p373-378. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy.

Authors : Onal, Cem^1,2 ; Guler, Ozan Cem¹; Elmali, Aysenur²

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p858-866. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer - a nation-wide cohort study.

Authors : Hyldgaard, Josephine M.^1,2 ; Nørgaard, Mette^1,3; Hjort, Peter E.^1,2

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p746-754. 12p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer.

Authors : Jahreiß, Marie-Christina¹; Incrocci, Luca¹; Aben, Katja K. H.²

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p511-517. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.

Authors : Støyten, Martin¹; Knutsen, Tore²; Stikbakke, Einar^1,3

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p154-163. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men.

Authors : Siltari, Aino^1,2 ; Murtola, Teemu J.^1,3; Kausz, Josefina¹

Source: Acta Oncologica. Dec2023, Vol. 62 Issue 12, p1898-1904. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists.

Authors : Bonde, Tiago M.¹ ; Garmo, Hans²; Stattin, Pär²

Source: Acta Oncologica. Dec2023, Vol. 62 Issue 12, p1815-1821. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Authors : Spampinato, Sofia¹ ; Rancati, Tiziana²; Waskiewicz, Justyna Magdalena³

Source: Acta Oncologica. Nov2023, Vol. 62 Issue 11, p1440-1450. 11p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Patient-reported lower limb edema after primary radiotherapy for prostate cancer.

Authors : Fokdal, Lars^1,2 ; Berg, Martin^1,3; Zedan, Ahmed H.¹

Source: Acta Oncologica. 2023, Vol. 62 Issue 10, p1279-1285. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT.

Authors : Klingenberg, Søren^1,2,3; Fredsøe, Jacob^2,3; Sørensen, Karina D.^2,3

Source: Acta Oncologica. Oct2022, Vol. 61 Issue 10, p1289-1294. 6p. 3 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Agent orange exposure and prostate cancer risk in the million veteran program.

The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy.

Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer - a nation-wide cohort study.

The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer.

Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men.

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists.

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Patient-reported lower limb edema after primary radiotherapy for prostate cancer.

Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT.

اتصل بنا

اتبع